Vaccine Development Challenges

The complexities of vaccine development are highlighted as Robin's team pivots to focus on variants and booster shots due to budget constraints. A promising self-amplifying RNA method could revolutionize vaccine production, allowing for significantly lower doses and reducing costs. This innovation aims to enhance global access, particularly in low and middle-income countries, where vaccine rollout has been alarmingly slow.